CAVA Group, Inc. CAVA

Key data

The business

CAVA sells fast-casual Mediterranean food: build-your-own bowls and pitas, house-made hummus, harissa and dressings, assembled on a make-line the way Chipotle builds a burrito. It owns and operates every restaurant, with no franchising, so all $1.18B of 2025 sales are its own and every new opening is its own capital at risk. The customer is the higher-income diner who traded up from a sandwich shop, and the whole equity story is one sentence: several hundred restaurants today, a runway the company frames in the thousands. The moat is a brand in a cuisine it largely defined, with no scaled national rival in Mediterranean, but a brand only compounds if the underlying restaurant math holds. That is the real question here, not the menu.

The numbers

The direction of travel is unmistakable and it just reaccelerated. Revenue has compounded about 24% a year since 2021, and the latest quarter did not fade into a plateau, it sped up.

Q2 FY26 revenue grew 31% over the same quarter a year earlier and net income 25%, with EPS of $0.19 clearing the $0.184 analysts looked for, the third beat in the last four prints. The plateau that would quietly disprove the compounder, the worry that traffic stalls and only new units carry the top line, did not show up in the headline this quarter; growth got faster, not slower. The caveat is that the traffic-versus-ticket split that would confirm existing restaurants are still winning guests is not in this pull, so the reacceleration is proven at the company level, not yet at the same-store level.

The pre-IPO per-share losses are share-count artifacts, ignore them. The line that traps the careless reader is FY2024 to FY2025: EPS looks like it halved, from $1.10 to $0.54. It did not. Operating income rose over that span; the drop is a roughly $87M gap between operating income and net income in 2024 washing out. The engine underneath is operating leverage, and it is real.

Operating cash flow was $185M in 2025 against $159M of capital spending, so the company self-funds nearly all its expansion and still ends with cash rising to $323M and no long-term debt. That is the compounder's whole appeal: plow the cash into new restaurants at 24% top-line growth while the margin on each dollar climbs. What the market does not seem to believe, and what I do, is that the derate has already priced a comp slowdown that the Q2 numbers have not delivered; the single print that settles it is the same-restaurant traffic figure next quarter.

Management

The insider tape is loud but reads mostly mechanical. Sales over the last year total $286M against $1.1M of buys, and one line dominates: Artal Participations, the pre-IPO backer, sold $271M on June 15, 2026. That is a financial sponsor distributing a position, not an operator voting on demand, and it says little about the business. Worth more attention is CEO Brett Schulman trimming about $3M the same day; plan status is not disclosed in the filings pulled, so whether that was scheduled or discretionary cannot be split here. Against results, management has beaten its own EPS mark in three of the last four quarters and funds growth without diluting or borrowing, which is the behavior you want from a self-financing expander.

How it fails or surprises you

The plateau (downside). If same-restaurant traffic goes flat and only new openings carry revenue, the 110x earnings multiple loses its floor fast. The Q2 headline reaccelerated to +31%, but the traffic split that confirms existing restaurants are still filling is undisclosed here. The print that reveals it first: same-restaurant sales, decomposed into traffic and ticket, next quarter.

The GAAP reckoning (downside). The market prices CAVA on unit growth, not reported profit. Reported EPS fell from $1.10 to $0.54, and if attention ever swings to GAAP earnings, 110 times a number that just declined is the value trap in plain sight. The print that settles it: FY2026 diluted EPS against FY2025's $0.54, tax noise stripped out.

Unit acceleration (right tail). If openings accelerate while restaurant-level margins hold and corporate overhead keeps leveraging, revenue compounds north of 20% with a widening margin and the 38% derate reverses. The market is not paying for this because it is braced for a comp slowdown. The print: net new restaurant count and restaurant-level margin, both currently outside this pull.

Closing thoughts

The same-restaurant traffic number next quarter decides whether this derate has overshot or the growth slowdown everyone fears has already begun. The stock has already fallen 38% from its high, which means much of the plateau fear is in the price; the same-restaurant traffic figure is the thing that converts that fear into either an entry or a confirmed trap. An ambiguous print, revenue up but traffic soft, leaves you paying a nosebleed multiple on a business carried by openings alone, and at that point survivability, not upside, is the only comfort, and here it is genuine: no debt, $323M of cash, self-funded growth. On balance the right tail looks the fatter one today because the most recent hard data reaccelerated rather than rolled over, but the multiple is unforgiving enough that a single weak comp does real damage.

The bet is still that CAVA keeps opening Mediterranean restaurants and keeps them full, paying for the build-out from its own cash. What breaks it is the plateau: existing restaurants quietly stalling while the headline leans on new units. The one pair of numbers that tells you first is same-restaurant traffic against net new openings, and if traffic turns negative while the store count does the lifting, the compounder story is over regardless of what the revenue line prints.